Drug Type Recombinant polypeptide, Biosimilar |
Synonyms Recombinant Teriparatide, 特立帕肽生物类似药(信立泰), 欣复泰 |
Target |
Mechanism PTH1R agonists(Parathyroid hormone receptor agonists), Osteogenesis stimulants, Parathyroid hormone replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (29 Sep 2019), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Teriparatide biosimilar(Shenzhen Salubris Pharmaceuticals Co., Ltd.) | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Osteoporosis, Postmenopausal | CN | 29 Sep 2019 |